Free Trial

Longevity Health (XAGE) Competitors

Longevity Health logo
$5.42 -0.28 (-4.91%)
As of 12:40 PM Eastern

XAGE vs. PAVM, SSKN, BTCY, NURO, SINT, CODX, TNON, LFWD, POAI, and ICU

Should you be buying Longevity Health stock or one of its competitors? The main competitors of Longevity Health include PAVmed (PAVM), Strata Skin Sciences (SSKN), Biotricity (BTCY), NeuroMetrix (NURO), Sintx Technologies (SINT), Co-Diagnostics (CODX), Tenon Medical (TNON), Lifeward (LFWD), Predictive Oncology (POAI), and SeaStar Medical (ICU). These companies are all part of the "medical equipment" industry.

Longevity Health vs. Its Competitors

PAVmed (NASDAQ:PAVM) and Longevity Health (NASDAQ:XAGE) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

PAVmed has a net margin of 3,711.54% compared to Longevity Health's net margin of -1,535.11%.

Company Net Margins Return on Equity Return on Assets
PAVmed3,711.54% N/A -42.29%
Longevity Health -1,535.11%N/A -280.07%

In the previous week, Longevity Health had 7 more articles in the media than PAVmed. MarketBeat recorded 9 mentions for Longevity Health and 2 mentions for PAVmed. PAVmed's average media sentiment score of 1.87 beat Longevity Health's score of 0.46 indicating that PAVmed is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PAVmed
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Longevity Health
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

PAVmed has higher revenue and earnings than Longevity Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PAVmed$1.99M4.98$39.79M$0.710.82
Longevity Health$50K108.40-$10.37MN/AN/A

19.9% of PAVmed shares are held by institutional investors. Comparatively, 24.2% of Longevity Health shares are held by institutional investors. 7.3% of PAVmed shares are held by company insiders. Comparatively, 29.0% of Longevity Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

PAVmed has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. Comparatively, Longevity Health has a beta of 0.49, suggesting that its share price is 51% less volatile than the S&P 500.

PAVmed presently has a consensus price target of $19.00, suggesting a potential upside of 3,170.22%. Given PAVmed's stronger consensus rating and higher probable upside, equities research analysts clearly believe PAVmed is more favorable than Longevity Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PAVmed
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Longevity Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

PAVmed beats Longevity Health on 9 of the 13 factors compared between the two stocks.

Get Longevity Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for XAGE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XAGE vs. The Competition

MetricLongevity HealthSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ Exchange
Market Cap$5.42M$60.50M$2.16B$9.26B
Dividend YieldN/AN/A2.60%4.03%
P/E RatioN/AN/A22.2719.56
Price / Sales108.4044.0398.98183.65
Price / CashN/A1.4013.3957.93
Price / Book-0.800.0673.625.58
Net Income-$10.37M-$82.29M-$134.41M$257.82M
7 Day Performance128.69%39.10%-0.42%-0.39%
1 Month PerformanceN/A32.15%0.77%7.80%
1 Year PerformanceN/A550.00%19.97%12.95%

Longevity Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XAGE
Longevity Health
N/A$5.42
-4.9%
N/AN/A$5.42M$50K0.0014News Coverage
Gap Up
PAVM
PAVmed
4.3716 of 5 stars
$0.60
-0.5%
$19.00
+3,081.0%
-39.0%$10.26M$2.99M0.8490News Coverage
Gap Up
SSKN
Strata Skin Sciences
3.3131 of 5 stars
$2.37
-1.3%
$6.00
+153.2%
-24.8%$10.01M$33.56M-1.04120
BTCY
Biotricity
N/A$0.39
-5.9%
N/A-53.1%$9.59M$12.06M-0.3640News Coverage
Gap Down
NURO
NeuroMetrix
N/A$4.55
+4.4%
N/A+23.3%$9.37M$3.03M-0.9920High Trading Volume
SINT
Sintx Technologies
3.5696 of 5 stars
$3.33
-4.0%
$28.00
+740.8%
-47.8%$8.71M$2.89M-0.0740Positive News
CODX
Co-Diagnostics
4.1366 of 5 stars
$0.25
-0.8%
$5.50
+2,100.0%
-79.2%$8.46M$3.91M-0.21100News Coverage
TNON
Tenon Medical
2.0256 of 5 stars
$1.02
-6.4%
$4.67
+357.5%
+38.8%$8.27M$3.28M-0.048News Coverage
LFWD
Lifeward
2.6564 of 5 stars
$0.73
-2.9%
$9.00
+1,135.2%
-81.4%$8.26M$25.66M-0.2460Gap Down
POAI
Predictive Oncology
2.4493 of 5 stars
$0.79
-1.3%
$3.00
+279.7%
-28.8%$7.06M$1.73M-0.2630News Coverage
ICU
SeaStar Medical
0.3288 of 5 stars
$0.59
-3.6%
N/A-92.4%$6.88M$140K-0.172Gap Up

Related Companies and Tools


This page (NASDAQ:XAGE) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners